Furthermore, the deficiency of MetO reductase A (MsrA) has been shown to promote vascular smooth muscle cell (VSMC) proliferation and neointimal hyperplasia through the extracellular signal‐regulated kinase 1/2 signaling pathway,28 which were also pathological changes associated with MMD. Here, MSRA is linked to multiminicore myopathy.